Fairmount Funds Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-931,890	Closed	-$32.3M	–	16
2024 Q2	$32.3M	Hold	931,890	–	–	3.65%	10
2024 Q1	$27M	Buy	+931,890	New	+$27M	2.94%	11
2022 Q2	–	Sell	-549,988	Closed	-$13M	–	28
2022 Q1	$13M	Buy	+549,988	New	+$13M	3.08%	14